Xiaoxian Li Selected Research

RS 20

4/2022

Utility of Oncotype DX score in clinical management for T1 estrogen receptor positive, HER2 negative, and lymph node negative breast cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Xiaoxian Li Research Topics

Disease

31	Breast Neoplasms (Breast Cancer) 05/2022 - 05/2008
31	Neoplasms (Cancer) 04/2022 - 06/2005
6	Triple Negative Breast Neoplasms 01/2022 - 10/2016
6	Pathologic Complete Response 01/2022 - 02/2015
5	Neoplasm Metastasis (Metastasis) 04/2022 - 06/2014
2	Disease Progression 05/2022 - 01/2019
2	Hepatocellular Carcinoma (Hepatoma) 01/2022 - 01/2020
1	Vomiting 01/2022
1	Pain (Aches) 01/2022
1	Liver Neoplasms (Liver Cancer) 01/2022
1	Lung Neoplasms (Lung Cancer) 01/2021
1	Lewis Lung Carcinoma 01/2021
1	Intraductal Papilloma 03/2020
1	Extranodal Extension 01/2020
1	Dehydration (Water Stress) 01/2019
1	Lymphatic Metastasis 10/2018
1	Genomic Instability 01/2018
1	Carcinoma (Carcinomatosis) 01/2017
1	Hypoxia (Hypoxemia) 06/2014
1	Myeloid Leukemia (Leukemia, Myelocytic) 06/2014
1	Noninfiltrating Intraductal Carcinoma (DCIS) 01/2014

Drug/Important Bio-Agent (IBA)

13	Estrogen ReceptorsIBA 04/2022 - 09/2006
9	Hormones (Hormone)IBA 10/2021 - 09/2006
7	Biomarkers (Surrogate Marker)IBA 08/2021 - 01/2017
5	Progesterone Receptors (Progesterone Receptor)IBA 10/2021 - 09/2006
3	Proteins (Proteins, Gene)FDA Link 01/2021 - 08/2009
3	ErbB Receptors (EGF Receptor)IBA 01/2019 - 05/2008
3	Trastuzumab (Herceptin)FDA Link 01/2019 - 02/2015
2	Eosine Yellowish-(YS) (Eosin)IBA 05/2022 - 01/2022
2	Hematoxylin (Haematoxylon)IBA 05/2022 - 01/2022
2	AntibodiesIBA 01/2021 - 01/2014
2	human ERBB2 proteinIBA 01/2019 - 10/2018
2	Lapatinib (GW572016)FDA Link 01/2019 - 05/2008
2	Acetates (Acetic Acid Esters)FDA Link 01/2019 - 01/2017
2	130-nm albumin-bound paclitaxelIBA 01/2019 - 02/2015
2	Biological ProductsIBA 04/2017 - 04/2015
2	ribosomal protein L39IBA 01/2017 - 06/2014
1	RS 20IBA 04/2022
1	Celecoxib (Celebrex)FDA Link 01/2022
1	perfluorobutane (AI 700)IBA 01/2022
1	parecoxibIBA 01/2022
1	Oxycodone (Oxycontin)FDA LinkGeneric 01/2022
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2022
1	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2022
1	Androgen Receptors (Androgen Receptor)IBA 10/2021
1	Tamoxifen FDA LinkGeneric 07/2021
1	Mechanistic Target of Rapamycin Complex 1IBA 07/2021
1	sapanisertibIBA 07/2021
1	tdTomatoIBA 01/2021
1	LuciferasesIBA 01/2021
1	VaccinesIBA 01/2021
1	4- (4- dihexadecylaminostyryl)- N- methylpyridium (DiA)IBA 04/2020
1	Inosine Diphosphate (IDP)IBA 03/2020
1	Sorafenib (BAY 43-9006)FDA Link 01/2020
1	FuransIBA 01/2019
1	Glucose (Dextrose)FDA LinkGeneric 01/2019
1	Everolimus FDA Link 01/2019
1	pertuzumabIBA 01/2019
1	3-hydroxybutanal (aldol)IBA 01/2019
1	levulinic acid (magnesium levulinate)IBA 01/2019
1	Paclitaxel (Taxol)FDA LinkGeneric 01/2019
1	Growth Factor ReceptorsIBA 01/2019
1	Ado-Trastuzumab EmtansineIBA 01/2019
1	5-hydroxymethylfurfural (hydroxymethylfurfural)IBA 01/2019
1	Cyclin-Dependent Kinase 9IBA 01/2018
1	Epidermal Growth Factor (EGF)IBA 12/2017
1	Pharmaceutical PreparationsIBA 01/2017
1	Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA 01/2017
1	Myeloid Cell Leukemia Sequence 1 ProteinIBA 01/2017
1	Arginine (L-Arginine)FDA Link 01/2017
1	EnzymesIBA 01/2017
1	RNA (Ribonucleic Acid)IBA 01/2017
1	Adenosine DeaminaseIBA 01/2017
1	Vinorelbine (Navelbine)FDA LinkGeneric 02/2015
1	Nitric Oxide Synthase (NO Synthase)IBA 06/2014
1	Small Interfering RNA (siRNA)IBA 06/2014
1	ParaffinIBA 01/2014
1	CateninsIBA 01/2014
1	Combined Antibody TherapeuticsIBA 01/2014
1	Cadherins (E-Cadherin)IBA 01/2014
1	Formaldehyde (Formol)FDA Link 01/2014
1	Coloring Agents (Dyes)IBA 01/2014
1	Docetaxel (Taxotere)FDA Link 08/2009
1	Surface Antigens (Surface Antigen)IBA 08/2009
1	ClaudinsIBA 08/2009
1	Letrozole (Femara)FDA LinkGeneric 08/2009
1	Carboxylesterase (Hydrolase S)IBA 01/2009
1	Inhibins (Inhibin)IBA 01/2009
1	VimentinIBA 01/2009

Therapy/Procedure

16	Therapeutics 05/2022 - 06/2005
13	Neoadjuvant Therapy 01/2022 - 05/2008
9	Drug Therapy (Chemotherapy) 04/2022 - 05/2008
2	Adjuvant Chemotherapy 04/2022 - 02/2015
2	Immunotherapy 01/2021 - 10/2020
2	Radiotherapy 10/2018 - 01/2017
1	Analgesia 01/2022
1	Lymph Node Excision (Lymph Node Dissection) 01/2020
1	Liver Transplantation 07/2019
1	Mastectomy (Mammectomy) 01/2017
1	Precision Medicine 01/2017